bumetanide has been researched along with Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, M | 1 |
| Venkatasubramanian, J | 1 |
| Boonkaewwan, C | 1 |
| Ganesan, N | 1 |
| Syed, A | 1 |
| Benya, RV | 1 |
| Rao, MC | 1 |
1 other study available for bumetanide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.
Topics: Alprostadil; Benzoates; Biological Transport; Bumetanide; Carcinoma; Cathartics; Cell Line, Tumor; C | 2011 |